Market Moves
Aurenar's V-Link ear-worn vagus-nerve stimulator receives FDA Breakthrough Device Designation for cerebral vasospasm in aneurysmal subarachnoid hemorrhage
Aurenar, a Washington University neurosurgery spinout led by Eric Leuthardt, received FDA Breakthrough Device Designation on 30 June 2026 for the V-Link System, a non-invasive transauricular vagus nerve stimulator targeting cerebral vasospasm in aneurysmal subarachnoid hemorrhage patients.